Cardiac POC Testing Devices is a cardiac related diagnostic test device that is performed at or near the patient’s point of care.
The global Cardiac POC Testing Devices market was valued at US$ 2265.8 million in 2019 and is expected to reach US$ 3366.1 million by the end of 2026, growing at a CAGR of 5.8% during 2021-2026.
This report focuses on Cardiac POC Testing Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cardiac POC Testing Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cardiac POC Testing Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Troponin test
Brain natriuretic peptide test
Others
Segment by Application
Clinics
Hospitals
Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche Diagnostics
Abaxis
Abbott
Beckman Coulter
Beckton and Dickinson
Bayer Diabetes Care
Hemocue AB
International Technidyne Corporation
LifeScan Inc
Nipro Diagnostics
Orasure Technologies
PointCare Technologies
Siemens HealthCare Diagnostics
The global Cardiac POC Testing Devices market was valued at US$ 2265.8 million in 2019 and is expected to reach US$ 3366.1 million by the end of 2026, growing at a CAGR of 5.8% during 2021-2026.
This report focuses on Cardiac POC Testing Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cardiac POC Testing Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cardiac POC Testing Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Troponin test
Brain natriuretic peptide test
Others
Segment by Application
Clinics
Hospitals
Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche Diagnostics
Abaxis
Abbott
Beckman Coulter
Beckton and Dickinson
Bayer Diabetes Care
Hemocue AB
International Technidyne Corporation
LifeScan Inc
Nipro Diagnostics
Orasure Technologies
PointCare Technologies
Siemens HealthCare Diagnostics
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.